News
Prices of medication and other costs could increase by as much as 12.9 percent if the tariffs are put in place ...
(Reuters) -Amgen on Friday announced a $900 million expansion of its Ohio biotech manufacturing facility, becoming the latest ...
The analysis, conducted by Ernst & Young, found the United States imported $203 billion in pharmaceutical products in 2023, ...
Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...
Sunscreen use is crucial for protecting children from harmful UV radiation, but experts stress the importance of also using ...
Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on ...
Big Pharma, long a lobbying powerhouse in Washington, is struggling to settle on a strategy for defending itself against ...
Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...
But recent weak U.S. prescription data is leading some investors and analysts to question whether that stellar run, which ...
Without a carve-out for tariff exceptions for pharmaceuticals, prices will skyrocket for US patients, experts warn.
We recently published a list of Jim Cramer Says Trump’s Fed Chair Tussle Is Like “The Godfather” & Discusses These 10 Stocks.
A growing number of pharmaceutical companies are sharing plans to ramp up domestic manufacturing capacity amid recent tariffs imposed by the Trump administration. Here are five things to know: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results